Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01208402 · ClinicalTrials.gov registry record · Phase 3
Esmolol for Treatment of Perioperative Tachycardia
A Phase 3 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 3
- Development phase
- 76
- Enrollment target
NCT01208402 is a Phase 3 study that was terminated before completion, run by Duke University. The registered enrollment target is 76 participants.
The verdict
NCT01208402, a Phase 3 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 76 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if Esmolol is a safe and effective alternative treatment compared to standard treatment using a long acting beta blocker drug, in controlling abnormal heart rate before, during and immediately after surgery.
Interventions
- DRUG Esmolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01208402
The ClinicalTrials.gov registry entry for NCT01208402 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Esmolol is the first listed.
NCT01208402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01208402 about?
NCT01208402 is a clinical study titled "Esmolol for Treatment of Perioperative Tachycardia". The purpose of this study is to find out if Esmolol is a safe and effective alternative treatment compared to standard treatment using a long acting beta blocker drug, in controlling abnormal heart rate before, during and immediately after surgery.
What is the current status of trial NCT01208402?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 76 participants. The study started on 2010-09. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01208402?
The interventions under investigation include: Esmolol (DRUG).
Who is sponsoring clinical trial NCT01208402?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.